Discovery and structural insight of a highly selective protein kinase inhibitor hit through click chemistry

Chemical Communications

Volumn 48, Issue 22, 2012, Pages 2788-2790

  Gu, Guoxian ^a   Wang, Huihui ^a   Liu, Pi ^a   Fu, Chenzeng ^a   Li, Zhonghua ^a   Cao, Xuefeng ^a   Li, Yunping ^a   Fang, Qinghong ^a   Xu, Feng ^a   Shen, Jie ^a   Wang, Peng George ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBAZOLE DERIVATIVE; DOXORUBICIN; GLYCOGEN SYNTHASE KINASE 3BETA; GRANULATIMIDE; INDOLE DERIVATIVE; K 252A; MALEIMIDE DERIVATIVE; PROTEIN KINASE INHIBITOR; STAUROSPORINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CLICK CHEMISTRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; MOLECULAR DOCKING;

EID: 84863178637     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c1cc15851a     Document Type: Article

References (17)

1. T. Pawson, J. D. Scott, Trends Biochem. Sci., 2005, 30, 286
2. L. Milanesi, M. Petrillo, L. Sepe, A. Boccia, N. D'Agostino, M. Passamano, S. DiNardo, G. Tasco, R. Casadio, G. Paolella, BMC Bioinformatics, 2005, 6, Suppl 4, S20
3. P. Cohen, Nat. Rev. Drug Discovery, 2002, 1, 309
4. C. Sanchez, C. Mendez, J. A. Salas, Nat. Prod. Rep., 2006, 23, 1007
5. G. Thoma, F. Nuninger, R. Falchetto, E. Hermes, G. A. Tavares, E. Vangrevelinghe, H.-G. Zerwes, J. Med. Chem., 2011, 54, 284
6. J. Wagner, P. von Matt, R. Sedrani, R. Albert, N. Cooke, C. Ehrhardt, M. Geiser, G. Rummel, W. Stark, A. Strauss, S. W. Cowan-Jacob, C. Beerli, G. Weckbecker, J.-P. Evenou, G. Zenke, S. Cottens, J. Med. Chem., 2009, 52, 6193
7. G.-H. Kuo, C. Prouty, A. DeAngelis, L. Shen, D. J. O'Neill, C. Shah, P. J. Connolly, W. V. Murray, B. R. Conway, P. Cheung, L. Westover, J. Z. Xu, R. A. Look, K. T. Demarest, S. Emanuel, S. A. Middleton, L. Jolliffe, M. P. Beavers, X. Chen, J. Med. Chem., 2003, 46, 4021
8. H. C. Kolb, M. G. Finn, K. B. Sharpless, Angew. Chem., Int. Ed., 2001, 40, 2004
9. H. C. Kolb, K. B. Sharpless, Drug Discovery Today, 2003, 8, 1128
10. M. Whiting, J. C. Tripp, Y. C. Lin, W. Lindstrom, A. J. Olson, J. H. Elder, K. B. Sharpless, V. V. Fokin, J. Med. Chem., 2006, 49, 7697
11. B. L. Wilkinson, L. F. Bornaghi, T. A. Houston and S.-A. Poulsen, in Drug Design Research Perspectives, ed. S. P. Kaplan, Nova, Hauppauge, 2007, p. 57
12. H. M. Relles, J. Org. Chem., 1972, 37, 3630-3637
13. J. Bain, H. McLauchlan, M. Elliott, P. Cohen, Biochem. J., 2003, 371, 199
14. R. Li and J. A. Stafford, Kinase inhibitor drugs, Wiley, Hoboken, NJ, 2009
15. C. R. Guimarăes, B. K. Rai, M. J. Munchhof, S. Liu, J. Wang, S. K. Bhattacharya, L. Buckbinder, J. Chem. Inf. Model., 2011, 51, 1199
16. M. E. Noble, J. A. Endicott, L. N. Johnson, Science, 2004, 303, 1800
17. J. Hou, C. Feng, Z. Li, Q. Fang, H. Wang, G. Gu, Y. Shi, P. Liu, F. Xu, Z. Yin, J. Shen, P. G. Wang, Eur. J. Med. Chem., 2011, 46, 3190